Key is the Q1 CY2019 for me, they really need to be hitting US$150m+ in revenue in CY19 which to me is breakeven.
Xylem is valued at 34x NPAT. Once Fluence can show consistently profitable Qs then they will raise a significantly larger amount in dual listing in US to further rapidly grow. Would be expecting $20m+ Profit in CY2020.
Next year / two are crucial for FLC to really show significant growth, BE then profitability.
Media update, page-2219
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
